← Open Payments lookup

SCARLETT IDEMA: Open Payments

NPI 1316520653 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$664 in 26 payments from 10 companies in 2025. Trend: 2023 $20 · 2024 $284 · 2025 $664

Food & beverage: $664
CompanyPaymentsAmount
Madrigal Pharmaceuticals15$431
Novo Nordisk Inc2$45
Cipher Pharmaceuticals US LLC1$42
Verona Pharma, Inc.2$33
ABIOMED1$25
Teva Pharmaceuticals USA, Inc.1$22
GlaxoSmithKline, LLC.1$17
Organon LLC1$17
Phadia US Inc.1$16
Gilead Sciences, Inc.1$16

Products named: REZDIFFRA, Ozempic, Natroba, Ohtuvayre, AUSTEDO XR, BEXSERO, NEXPLANON, ImmunoCAP.

Industry payments across MI — which companies pay providers there.